13F

Stock

Trevi Therapeutics, Inc.

TRVI · held by 7 managers

Reported value

$58.8M

Holders

7

+1 new · −0 exited

Holders’ est. mark

$798.1K

Price effect on 1 books still in the name

Largest holder

$39.4M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY4.3M$39.4MHeld
BANK OF AMERICA CORP /DE/1.84M$16.8MHeld
BARCLAYS PLC216.9K$1.98M$798.1KCut−$835.2K
CANTOR FITZGERALD, L. P.50.9K$465.4KHeld
Persistent Asset Partners Ltd19.7K$180.1KHeld
Allworth Financial LP53$485Held
Essential Partners LLC11$101New

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.